Evofem Biosciences and Orion Biotechnology Launch Collaboration to Develop MPT Product Candidate to Include HIV Prevention
- Thursday, December 16, 2021, 7:04
- Finance
- Add a comment
SAN DIEGO, Dec. 16, 2021 /PRNewswire/ — Evofem Biosciences, Inc. (NASDAQ: EVFM) and Orion Biotechnology Canada Ltd. today announced that they have entered into a collaboration agreement to evaluate the compatibility and stability of Orion’s novel CCR5 antagonist, OB-002, in Evofem’s…
About the Author
adminasapcorp has written 42014 stories on this site.